BioCentury
ARTICLE | Company News

AntiCancer, U.S. BioDefense Inc. deal

October 24, 2005 7:00 AM UTC

The companies partnered to develop therapeutics for neural diseases using human neural crest stem cells. Further terms were not disclosed. ...